MX2014004688A - Proceso de obtencion de acidos isoxazolil-metoxi-nicotinicos. - Google Patents

Proceso de obtencion de acidos isoxazolil-metoxi-nicotinicos.

Info

Publication number
MX2014004688A
MX2014004688A MX2014004688A MX2014004688A MX2014004688A MX 2014004688 A MX2014004688 A MX 2014004688A MX 2014004688 A MX2014004688 A MX 2014004688A MX 2014004688 A MX2014004688 A MX 2014004688A MX 2014004688 A MX2014004688 A MX 2014004688A
Authority
MX
Mexico
Prior art keywords
preparation
isoxazolyl
methoxy
nicotinic acids
compound
Prior art date
Application number
MX2014004688A
Other languages
English (en)
Spanish (es)
Inventor
Stefan Hildbrand
Pascal Dott
Steven Paul Hanlon
Hans Iding
Andrew Thomas
Pius Waldmeier
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2014004688A publication Critical patent/MX2014004688A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y305/00Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/05Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in nitriles (3.5.5)
    • C12Y305/05001Nitrilase (3.5.5.1)

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MX2014004688A 2011-10-20 2012-10-17 Proceso de obtencion de acidos isoxazolil-metoxi-nicotinicos. MX2014004688A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11185992 2011-10-20
PCT/EP2012/070521 WO2013057123A1 (en) 2011-10-20 2012-10-17 Process for the preparation of isoxazolyl-methoxy-nicotinic acids

Publications (1)

Publication Number Publication Date
MX2014004688A true MX2014004688A (es) 2014-05-28

Family

ID=47019026

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014004688A MX2014004688A (es) 2011-10-20 2012-10-17 Proceso de obtencion de acidos isoxazolil-metoxi-nicotinicos.

Country Status (20)

Country Link
US (1) US8604062B2 (https=)
EP (1) EP2768827B1 (https=)
JP (1) JP5923174B2 (https=)
KR (2) KR20140084209A (https=)
CN (1) CN103889978B (https=)
AR (1) AR088358A1 (https=)
AU (1) AU2012321095B2 (https=)
BR (1) BR112014009266B1 (https=)
CA (2) CA3112072C (https=)
DK (1) DK2768827T3 (https=)
ES (1) ES2613802T3 (https=)
HU (1) HUE031276T2 (https=)
IL (1) IL231645A (https=)
MX (1) MX2014004688A (https=)
MY (1) MY164880A (https=)
PL (1) PL2768827T3 (https=)
RU (1) RU2014118966A (https=)
SG (1) SG11201401626UA (https=)
SI (1) SI2768827T1 (https=)
WO (1) WO2013057123A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020004116A2 (pt) * 2017-08-28 2020-09-01 University Of Maryland, Baltimore novos moduladores do receptor de ácido gama aminobutírico tipo a para distúrbios de humor
IL279266B2 (en) 2018-06-13 2024-03-01 Hoffmann La Roche New isoxazolyl ether derivatives as gaba a alpha5 pam
HU231223B1 (hu) 2018-09-28 2022-01-28 Richter Gedeon Nyrt. GABAA A5 receptor modulátor hatású biciklusos vegyületek
EP4126858B1 (en) 2020-03-26 2026-03-18 Richter Gedeon Nyrt. Dihydro-2-pyrrolo[3,4-c]pyridine derivatives as gabaa a5 receptor modulators
GB202013765D0 (en) * 2020-09-02 2020-10-14 Gw Res Ltd Method of preparing cannabinoids
CN116854680A (zh) 2022-03-28 2023-10-10 上海赛默罗生物科技有限公司 异噁唑-杂环类衍生物、药物组合物和用途
CN119265168B (zh) * 2024-11-05 2025-06-20 江南大学 一种新型腈水解酶及其在烟酸生物合成中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1102755B1 (en) 1998-08-07 2006-01-04 Chiron Corporation Substituted isoxazole derivatives as estrogen receptor modulators
US6551804B2 (en) * 1999-07-12 2003-04-22 E. I. Du Pont De Nemours And Company Process for preparing 4-cyanopentanoic acid
US20060148858A1 (en) 2002-05-24 2006-07-06 Tsuyoshi Maekawa 1, 2-Azole derivatives with hypoglycemic and hypolipidemic activity
GB0221443D0 (en) 2002-09-16 2002-10-23 Glaxo Group Ltd Pyridine derivates
UA82292C2 (uk) * 2004-04-14 2008-03-25 Пфайзер Продактс Инк. Спосіб стереоселективного біоперетворення аліфатичних динітрилів в ціанокарбонові кислоти (варіанти)
WO2005113519A1 (en) 2004-05-14 2005-12-01 Irm Llc Compounds and compositions as ppar modulators
ATE415385T1 (de) 2004-10-01 2008-12-15 Hoffmann La Roche Hexafluorisopropanolsubstituierte etherderivate
DE602006017694D1 (de) 2005-06-27 2010-12-02 Bristol Myers Squibb Co C-verknüpfte zyklische antagonisten des p2y1-rezeptors mit eignung bei der behandlung thrombotischer leiden
EP1931661B1 (en) 2005-09-19 2008-11-19 F.Hoffmann-La Roche Ag Isoxazolo derivatives as gaba a alpha5 inverse agonists
WO2007042420A1 (en) 2005-10-11 2007-04-19 F. Hoffmann-La Roche Ag Isoxazole derivatives
RU2426731C2 (ru) 2005-12-23 2011-08-20 Ф. Хоффманн-Ля Рош Аг Производные арил-изоксазоло-4-ил-оксадиазола
WO2009071464A1 (en) 2007-12-04 2009-06-11 F. Hoffmann-La Roche Ag Isoxazolo-pyrazine derivatives
US7943619B2 (en) 2007-12-04 2011-05-17 Hoffmann-La Roche Inc. Isoxazolo-pyridazine derivatives
UA100132C2 (en) * 2007-12-04 2012-11-26 Ф. Хоффманн-Ля Рош Аг Isoxazolo-pyridine derivatives
JP2012040448A (ja) * 2008-11-14 2012-03-01 Yasutaka Sakamoto マイクロバブル発生装置
US8222246B2 (en) 2009-04-02 2012-07-17 Hoffmann-La Roche Inc. Substituted isoxazoles
MX2011011484A (es) 2009-05-07 2011-11-18 Hoffmann La Roche Derivados de isoxazol-piridina como moduladores del acido gamma-aminobutirico.

Also Published As

Publication number Publication date
WO2013057123A1 (en) 2013-04-25
PL2768827T3 (pl) 2017-05-31
KR20200008671A (ko) 2020-01-28
CA2850440C (en) 2021-05-04
EP2768827A1 (en) 2014-08-27
KR20140084209A (ko) 2014-07-04
JP5923174B2 (ja) 2016-05-24
IL231645A (en) 2016-09-29
BR112014009266A2 (pt) 2017-06-13
BR112014009266B1 (pt) 2021-05-04
DK2768827T3 (en) 2017-02-13
JP2014530831A (ja) 2014-11-20
US20130102778A1 (en) 2013-04-25
AU2012321095B2 (en) 2015-08-20
BR112014009266A8 (pt) 2020-04-22
KR102262697B1 (ko) 2021-06-11
RU2014118966A (ru) 2015-11-27
CA3112072C (en) 2023-06-13
NZ622214A (en) 2016-08-26
CA3112072A1 (en) 2013-04-25
HUE031276T2 (hu) 2017-07-28
MY164880A (en) 2018-01-30
ES2613802T3 (es) 2017-05-26
CN103889978B (zh) 2017-02-15
CN103889978A (zh) 2014-06-25
CA2850440A1 (en) 2013-04-25
SG11201401626UA (en) 2014-05-29
AU2012321095A1 (en) 2013-05-09
IL231645A0 (en) 2014-05-28
US8604062B2 (en) 2013-12-10
EP2768827B1 (en) 2016-11-23
AR088358A1 (es) 2014-05-28
SI2768827T1 (sl) 2017-04-26

Similar Documents

Publication Publication Date Title
JOP20210065A1 (ar) عملية لتحضير 5- فلورو-1h- بيرازولوبيريدينات مستبدلة
MX2020010330A (es) Proceso para preparar un compuesto antiviral de formula i.
PH12017501429A1 (en) Derivatives of betulin
MY183312A (en) Pharmaceutical formulation
MD20180040A2 (ro) Inhibitori ai virusului hepatic C
MY165087A (en) Neprilysin inhibitors
EA201490724A1 (ru) Замещенные соединения тетрагидроизохинолина в качестве ингибиторов фактора xia
MX348654B (es) Composicion farmaceutica con biodisponibilidad mejorada para compuesto hidrofobico de alto punto de fusion.
IN2014CN04449A (https=)
IN2014MN01521A (https=)
MX2014004688A (es) Proceso de obtencion de acidos isoxazolil-metoxi-nicotinicos.
IN2014DN00144A (https=)
PT2462098E (pt) Processos para a preparação de derivados de ácido 1-(2- halobifenil-4-il)-ciclopropanocarboxílico
MY157423A (en) Production method of intermediate compound for synthesizing medicament
MX2013000009A (es) Procedimiento de preparacion de la sal de l-arginina de perindoprilo.
MX2010009926A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico.
WO2014087208A3 (en) A process of preparing alcaftadine
MY191759A (en) Processes for the preparation of pyrimidinylcyclopentane compounds
IN2014DN09451A (https=)
SG194711A1 (en) Processes for preparing inhibitors of the hepatitis c virus
IN2014DN03245A (https=)
MX2013004193A (es) Procedimiento para la preparacion de derivados de acido 3-(6-amino-piridin-3-il)-2-acrilico.
WO2013046233A3 (en) Process for the preparation of octreotide acetate
SA112330994B1 (ar) عملية جديدة لتخليق إيفابردين وأملاح الإضافة الخاصة به مع حمض مقبول صيدلانياً
WO2011157670A3 (en) Process for the preparation of benzamide derivatives